{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49dv1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49d_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10107","date":"2024-07-01T16:14:26.454Z","role":"Publisher"},{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49d_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10107","date":"2024-07-01T18:00:00.000Z","role":"Approver"}],"curationReasons":{"id":"cg:NewCuration"},"evidence":[{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49d_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49d_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:cf3c5efa-9bf4-4fd4-8a8b-a715cb8d8e12","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:02aa2e56-32ba-450e-8a01-967ed22b65b3","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"In humans, AGS can present with microcephaly, cerebral hemorrhage, and motor dysfunction, among many other phenotypes. In this zebrafish model, microcephaly, cerebral hemorrhages and motor dysfunction were observed in the samhd1 delta23 mutant line.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/36949945","type":"dc:BibliographicResource","dc:abstract":"Aicardi-Goutières syndrome (AGS1-9) is a genetically determined encephalopathy that falls under the type I interferonopathy disease class, characterized by excessive type I interferon (IFN-I) activity, coupled with upregulation of IFN-stimulated genes (ISGs), which can be explained by the vital role these proteins play in self-non-self-discrimination. To date, few mouse models fully replicate the vast clinical phenotypes observed in AGS patients. Therefore, we investigated the use of zebrafish as an alternative species for generating a clinically relevant model of AGS. Using CRISPR-cas9 technology, we generated a stable mutant zebrafish line recapitulating AGS5, which arises from recessive mutations in ","dc:creator":"Withers SE","dc:date":"2023","dc:title":"Characterization of a mutant "},"rdfs:label":"SAMHD1 Mutant Zebrafish"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1,"dc:description":"Since this is a non-mammalian model, we have downgraded to 1 point."}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49d_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49d_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:2486b7a0-4036-4bd3-aca5-13265c9dd218_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2486b7a0-4036-4bd3-aca5-13265c9dd218","type":"Proband","allele":{"id":"cggv:d2fba358-c412-44ef-bb7d-cfd54bb6a17a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.625G>A (p.Gly209Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340140"}},"detectionMethod":"single gene testing","firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"cggv:4458d4c8-c91a-4d7e-b037-2981949fb0ad_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d2fba358-c412-44ef-bb7d-cfd54bb6a17a"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/19525956","type":"dc:BibliographicResource","dc:abstract":"Aicardi-Goutières syndrome is a mendelian mimic of congenital infection and also shows overlap with systemic lupus erythematosus at both a clinical and biochemical level. The recent identification of mutations in TREX1 and genes encoding the RNASEH2 complex and studies of the function of TREX1 in DNA metabolism have defined a previously unknown mechanism for the initiation of autoimmunity by interferon-stimulatory nucleic acid. Here we describe mutations in SAMHD1 as the cause of AGS at the AGS5 locus and present data to show that SAMHD1 may act as a negative regulator of the cell-intrinsic antiviral response.","dc:creator":"Rice GI","dc:date":"2009","dc:title":"Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response."}},"rdfs:label":"Rice AGS76 Proband"},{"id":"cggv:4458d4c8-c91a-4d7e-b037-2981949fb0ad","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:4458d4c8-c91a-4d7e-b037-2981949fb0ad_variant_evidence_item"},{"id":"cggv:4458d4c8-c91a-4d7e-b037-2981949fb0ad_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization."}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:15128693-bde8-4945-a6aa-8f80dca67154_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:15128693-bde8-4945-a6aa-8f80dca67154","type":"Proband","allele":[{"id":"cggv:6f6ac06a-7610-46f7-a5eb-eac85acd1e44","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.1324C>T (p.Arg442Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345512"}},{"id":"cggv:19601ec9-e391-4dfa-b7f7-2b557de18814","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.434G>A (p.Arg145Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345523"}}],"detectionMethod":"single gene testing","firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":[{"id":"cggv:6d13e242-c8d4-400a-8971-90b9c2c001ea_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:6f6ac06a-7610-46f7-a5eb-eac85acd1e44"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956"},{"id":"cggv:f733c07f-d569-44d3-ad18-3b8697f27bcd_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:19601ec9-e391-4dfa-b7f7-2b557de18814"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956"}],"rdfs:label":"Rice AGS91 Proband"},{"id":"cggv:6d13e242-c8d4-400a-8971-90b9c2c001ea","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:6d13e242-c8d4-400a-8971-90b9c2c001ea_variant_evidence_item"},{"id":"cggv:6d13e242-c8d4-400a-8971-90b9c2c001ea_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization"}],"strengthScore":2},{"id":"cggv:f733c07f-d569-44d3-ad18-3b8697f27bcd","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:f733c07f-d569-44d3-ad18-3b8697f27bcd_variant_evidence_item"},{"id":"cggv:f733c07f-d569-44d3-ad18-3b8697f27bcd_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization"}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:d3ff30dd-e485-46db-85b4-596ba0f8d4d7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:d3ff30dd-e485-46db-85b4-596ba0f8d4d7","type":"Proband","allele":{"id":"cggv:a7d1a494-a6ee-4af7-b904-3702a20ac71b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.1153A>G (p.Met385Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345510"}},"detectionMethod":"Affymetrix GeneChip SNP Human Mapping 50,000 array (50K Xba240). We conducted high-density genotyping using established microsatellite markers and novel markers (D20SG1, D20SG2, D20SG5, D20SG6, D20SG7) derived from the UCSC Human Genome Browser sequence (March 2006 freeze). Microsatellite genotyping was done by standard PCR amplification using fluorescent primers and analysis on an ABI 3130.","firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains. ","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"cggv:ba5c461a-addb-4060-af6d-e82b4aad51f4_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a7d1a494-a6ee-4af7-b904-3702a20ac71b"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956"},"rdfs:label":"Rice AGS109 Proband"},{"id":"cggv:ba5c461a-addb-4060-af6d-e82b4aad51f4","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:ba5c461a-addb-4060-af6d-e82b4aad51f4_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:49c8cbce-a5a9-477b-aef8-4f319246a461_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:49c8cbce-a5a9-477b-aef8-4f319246a461","type":"Proband","allele":{"id":"cggv:59d4ae51-cb3f-4489-85bb-c0f1e30e43a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.445C>T (p.Gln149Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340145"}},"detectionMethod":"Affymetrix GeneChip SNP Human Mapping 50,000 array (50K Xba240). We conducted high-density genotyping using established microsatellite markers and novel markers (D20SG1, D20SG2, D20SG5, D20SG6, D20SG7) derived from the UCSC Human Genome Browser sequence (March 2006 freeze). Microsatellite genotyping was done by standard PCR amplification using fluorescent primers and analysis on an ABI 3130.","firstTestingMethod":"Homozygosity mapping","phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains.","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"cggv:c0170a4f-27bc-41ec-9bee-a35a6c4388c2_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:59d4ae51-cb3f-4489-85bb-c0f1e30e43a4"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956"},"rdfs:label":"Rice AGS128 Proband"},{"id":"cggv:c0170a4f-27bc-41ec-9bee-a35a6c4388c2","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:c0170a4f-27bc-41ec-9bee-a35a6c4388c2_variant_evidence_item"},{"id":"cggv:c0170a4f-27bc-41ec-9bee-a35a6c4388c2_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization"}],"strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:6484f7b8-df11-46cb-8d95-575b2ac0b6b0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:6484f7b8-df11-46cb-8d95-575b2ac0b6b0","type":"Proband","allele":[{"id":"cggv:e9b469dc-992b-4b0b-ae43-61f04a6f13d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.427C>T (p.Arg143Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342741"}},{"id":"cggv:ddcf3766-5635-43b4-80b9-33cd2447bce3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.602T>A (p.Ile201Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA249482"}}],"detectionMethod":"sequencing of single gene","firstTestingMethod":"PCR","phenotypeFreeText":"developmental delay, microcephaly, cortical visual impairment, periventricular calcification with ventriculomegaly, violaceous discoloration of the fingers and toes, leukocytoclastic vasculitis, progressive loss of neurological function,bilateral basal ganglia\ncalcification, calcification at the white–grey matter junction, low attenuation in the frontal white matter with subsequent extensive loss of white matter, large subarachnoid haemorrhage","sex":"Female","variant":[{"id":"cggv:e597e224-a777-42ab-8468-0b02f1ed45a0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e9b469dc-992b-4b0b-ae43-61f04a6f13d4"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/20653736","type":"dc:BibliographicResource","dc:abstract":"To describe a spectrum of intracerebral large artery disease in Aicardi-Goutières syndrome (AGS) associated with mutations in the AGS5 gene SAMHD1.","dc:creator":"Ramesh V","dc:date":"2010","dc:title":"Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis."}},{"id":"cggv:24df8320-20c3-497d-9b08-916f30b0998d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ddcf3766-5635-43b4-80b9-33cd2447bce3"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736"}],"rdfs:label":"Ramesh Case 3"},{"id":"cggv:24df8320-20c3-497d-9b08-916f30b0998d","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:24df8320-20c3-497d-9b08-916f30b0998d_variant_evidence_item"},{"id":"cggv:24df8320-20c3-497d-9b08-916f30b0998d_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization."}],"strengthScore":0.5},{"id":"cggv:e597e224-a777-42ab-8468-0b02f1ed45a0","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:e597e224-a777-42ab-8468-0b02f1ed45a0_variant_evidence_item"},{"id":"cggv:e597e224-a777-42ab-8468-0b02f1ed45a0_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"No","dc:description":"   "}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:382eb054-67bc-47c9-93bb-bfcb79150319_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:382eb054-67bc-47c9-93bb-bfcb79150319","type":"Proband","allele":[{"id":"cggv:32326ee5-407b-489f-a906-b1801bd4ecb8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.368A>C (p.His123Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340151"}},{"id":"cggv:204e4137-7204-4ece-8607-2a7057fe6b21","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.760A>G (p.Met254Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340153"}}],"detectionMethod":"single gene testing","firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":[{"id":"cggv:262515ea-5ef9-4814-a7a4-ad6b65a10e7e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:32326ee5-407b-489f-a906-b1801bd4ecb8"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956"},{"id":"cggv:616a45f4-b6fe-4100-a53d-f17e62b07bec_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:204e4137-7204-4ece-8607-2a7057fe6b21"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956"}],"rdfs:label":"Rice AGS82 Proband"},{"id":"cggv:616a45f4-b6fe-4100-a53d-f17e62b07bec","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:616a45f4-b6fe-4100-a53d-f17e62b07bec_variant_evidence_item"},{"id":"cggv:616a45f4-b6fe-4100-a53d-f17e62b07bec_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization"}],"strengthScore":0.5},{"id":"cggv:262515ea-5ef9-4814-a7a4-ad6b65a10e7e","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:262515ea-5ef9-4814-a7a4-ad6b65a10e7e_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:682f8057-5efb-4c4e-8dd9-d5fca9da328d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:682f8057-5efb-4c4e-8dd9-d5fca9da328d","type":"Proband","allele":{"id":"cggv:18aa9f13-c682-49dc-b697-0c60f05218c3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.428G>A (p.Arg143His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345521"}},"detectionMethod":"single gene testing","firstTestingMethod":"PCR","phenotypeFreeText":"All affected individuals included in this study fulfilled diagnostic criteria for Aicardi-Goutières syndrome, with neurological features of an early-onset encephalopathy, negative investigations for common prenatal infections, intracranial calcification in a typical distribution, a cerebrospinal fluid lymphocytosis >5 cells/mm3 and/or >2 IU/ml of IFN-α in the cerebrospinal fluid and/or chilblains.","sex":"UnknownEthnicity","variant":{"id":"cggv:226e9126-0658-475c-a1bb-a76063f2c3da_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:18aa9f13-c682-49dc-b697-0c60f05218c3"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/19525956"},"rdfs:label":"Rice AGS126 Proband"},{"id":"cggv:226e9126-0658-475c-a1bb-a76063f2c3da","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:226e9126-0658-475c-a1bb-a76063f2c3da_variant_evidence_item"}],"strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:077d6276-2f81-4245-a433-5cf648ae938f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:077d6276-2f81-4245-a433-5cf648ae938f","type":"Proband","allele":[{"id":"cggv:fdc880eb-4560-4ce4-bf76-5a42a89ec17d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.433C>T (p.Arg145Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340142"}},{"id":"cggv:75dad4bb-0287-4b26-9317-b0d1f2aafd4b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.490C>T (p.Arg164Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252975"}}],"phenotypeFreeText":"postnatal microcephaly, mild learning difficulties, intermittent violaceous urticaria-like rash, mouth ulcers, chilblains, arthropathy","sex":"Female","variant":[{"id":"cggv:744de4b2-b867-47d8-a335-397cda29ce2c_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:fdc880eb-4560-4ce4-bf76-5a42a89ec17d"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/20358604","type":"dc:BibliographicResource","dc:abstract":"We report on two siblings doubly heterozygous for null mutations in the recently identified AGS5 gene SAMHD1. The older female child showed mild intellectual disability with microcephaly. Her brother demonstrated a significant spastic paraparesis with normal intellect and head size. Both children had an unclassified chronic inflammatory skin condition with chilblains, and recurrent mouth ulcers. One child had a chronic progressive deforming arthropathy of the small and large joints, with secondary contractures. This family illustrate the remarkable phenotypic diversity accruing from mutations in genes associated with Aicardi-Goutières syndrome (AGS). The association of arthropathy with SAMHD1 mutations highlights a phenotypic overlap of AGS with familial autoinflammatory disorders such as chronic infantile neurological cutaneous and articular syndrome (CINCA). This family therefore illustrate the need to consider mutation analysis of SAMHD1 in non-specific inflammatory phenotypes of childhood. We propose that arthropathy with progressive contractures should now be considered part of the spectrum of Aicardi-Goutières syndrome because of SAMHD1 mutations.","dc:creator":"Dale RC","dc:date":"2010","dc:title":"Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures."}},{"id":"cggv:9d095968-0365-4b2a-b589-ef959181477f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:75dad4bb-0287-4b26-9317-b0d1f2aafd4b"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/20358604"}],"rdfs:label":"Dale Female Sib"},{"id":"cggv:9d095968-0365-4b2a-b589-ef959181477f","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:9d095968-0365-4b2a-b589-ef959181477f_variant_evidence_item"},{"id":"cggv:9d095968-0365-4b2a-b589-ef959181477f_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization"}],"strengthScore":2},{"id":"cggv:744de4b2-b867-47d8-a335-397cda29ce2c","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:744de4b2-b867-47d8-a335-397cda29ce2c_variant_evidence_item"},{"id":"cggv:744de4b2-b867-47d8-a335-397cda29ce2c_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization"}],"strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:341f67ac-54fe-4ad3-9716-c66dcbc17e4d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:341f67ac-54fe-4ad3-9716-c66dcbc17e4d","type":"Proband","allele":{"id":"cggv:0e74b87f-9285-4e22-9b14-44c1d207bfce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015474.4(SAMHD1):c.1503+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345516"}},"detectionMethod":"sequencing of single gene","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"PCR","phenotypeFreeText":"glaucoma, multiple generalized convulsive seizures, intracranial calcification, raised intraocular pressure, cerebral palsy, ulceration of the tips of his fingers, toes, ears, and nose exacerbated by cold weather; contractures; anterior cerebral artery territory infarcts; stenosis of the supra-clinoid internal carotid arteries","sex":"Male","variant":{"id":"cggv:97635241-7f17-409c-a954-d931981f2bd3_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0e74b87f-9285-4e22-9b14-44c1d207bfce"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736"},"rdfs:label":"Ramesh Case 2"},{"id":"cggv:97635241-7f17-409c-a954-d931981f2bd3","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:97635241-7f17-409c-a954-d931981f2bd3_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a6bef983-ae48-4882-a55e-a792dc41952c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a6bef983-ae48-4882-a55e-a792dc41952c","type":"Proband","allele":{"id":"cggv:ddcf3766-5635-43b4-80b9-33cd2447bce3"},"detectionMethod":"sequencing of single gene","firstTestingMethod":"PCR","phenotypes":["obo:HP_0009710","obo:HP_0002135","obo:HP_0002510","obo:HP_0011834","obo:HP_0003593","obo:HP_0030880"],"sex":"Female","variant":{"id":"cggv:08c5c0cd-95ad-4062-9ee4-d674770c2ff3_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:ddcf3766-5635-43b4-80b9-33cd2447bce3"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/20653736"},"rdfs:label":"Ramesh Case 1"},{"id":"cggv:08c5c0cd-95ad-4062-9ee4-d674770c2ff3","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:08c5c0cd-95ad-4062-9ee4-d674770c2ff3_variant_evidence_item"},{"id":"cggv:08c5c0cd-95ad-4062-9ee4-d674770c2ff3_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Goncalves et al 2012 [PMID 22461318]: HeLa cells were transiently transfected with SAMHD1 WT or mutant constructs. Mutant constructs with this variant demonstrated altered subcellular localization."}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8637,"specifiedBy":"GeneValidityCriteria10","strengthScore":13,"subject":{"id":"cggv:367ad743-6999-480a-9c3c-1d7e6b459ea9","type":"GeneValidityProposition","disease":"obo:MONDO_0700260","gene":"hgnc:15925","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"SAMHD1 was first reported in relation to autosomal recessive Aicardi-Goutieres Syndrome Type 5 (OMIM: 612952) in 2009 when it was shown to act as a negative regulator of the cell-intrinsic antiviral response  (Rice et al., PMID: 19525956). \n\nThe described autosomal recessive SAMHD1 phenotype is considered to be a form of type 1 interferonopathy, which is defined as a condition in which increased type 1 interferon signaling leads to autoimmune and neurological disorders (MONDO:0700260). These disorders are caused by variants in genes involved in nucleic acid metabolism, sensing, and the innate immune response. Individuals with biallelic variants in SAMHD1 can present with a range of symptoms of variable severity and age of onset, within the context of an autoimmune disease. \n\nTwenty variants (missense, frameshift) that have been reported in 10 probands in 3 publications (PMIDs: 20358604, 20653736, 19525956) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity thought to be to be loss of function. This gene-disease relationship is also supported by experimental evidence (model system studies, PMID: 36949945). One study demonstrated that homozygous mutant zebrafish larvae possess a number of neurological phenotypes, exemplified by variable, but increased expression of several ISGs in the head region, a significant increase in brain cell death, microcephaly and locomotion deficits align with human phenotypes. In summary, there is definitive evidence supporting the relationship between SAMHD1 and autosomal recessive SAMHD1-related type 1 interferonopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Leukodystrophy and Leukoencephalopathy GCEP on the meeting date April 29, 2024 (SOP Version 10).","dc:isVersionOf":{"id":"cggv:fdb550bf-9374-440d-b5cd-29ba7c64c49d"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}